arsenic trioxide
PolandDrugs containing this active substance
-
The medicine is intended for adult patients with newly diagnosed low or intermediate-risk acute promyelocytic leukemia (APL), as well as for individuals for whom this disease does not respond to other therapies.
Form: solution for infusion, concentrate
Active substance Dosage arsenic trioxide 2 mg/ml ATC: L01XX27
Manufacturer: Tillomed Malta Limited